Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Mehta

Showing results (1101-1110 of 1,180) with videos related to

Pageof 118
Sort By:
European Heart Journal. Cardiovascular Pharmacotherapy|January 17, 2023
Ticagrelor with or without aspirin in high-risk patients with anaemia undergoing percutaneous coronary intervention: a subgroup analysis of the TWILIGHT trialAlessandro Spirito, Adnan Kastrati, Davide Cao, et al.
CJC Open|December 23, 2022
Design and Rationale of Routine <b>U</b>ltrasou<b>N</b>d Gu<b>I</b>dance for <b>V</b>ascular Acc<b>E</b>ss fo<b>R</b> Cardiac Procedure<b>s</b>: <b>A</b> Randomized Tria<b>L</b> (UNIVERSAL)Sulaiman Alrashidi, Marc-André d'Entremont, Omar Alansari, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|August 22, 2018
Clinical chemistry score versus high-sensitivity cardiac troponin I and T tests alone to identify patients at low or high risk for myocardial infarction or death at presentation to the emergency departmentPeter A Kavsak, Johannes T Neumann, Louise Cullen, et al.
Heart and Vessels|January 28, 2022
Use and outcomes of dual antiplatelet therapy for acute coronary syndrome in patients with chronic kidney disease: insights from the Canadian Observational Antiplatelet Study (COAPT)Carol Anne Graham, Mary K Tan, Derek P Chew, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|June 29, 2023
No-reflow after primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction: an angiographic core laboratory analysis of the TOTAL TrialMarc-André d'Entremont, Ashraf Alazzoni, Vladimir Dzavik, et al.
European Heart Journal|March 28, 2012
The relationship between CYP2C19 polymorphisms and ischaemic and bleeding outcomes in stable outpatients: the CHARISMA genetics studyDeepak L Bhatt, Guillaume Paré, John W Eikelboom, et al.
Journal of the American College of Cardiology|April 3, 2020
Ticagrelor With or Without Aspirin in High-Risk Patients With Diabetes Mellitus Undergoing Percutaneous Coronary InterventionDominick J Angiolillo, Usman Baber, Samantha Sartori, et al.
The Journal of Clinical Investigation|March 14, 2017
T cells control the generation of nanomolar-affinity anti-glycan antibodiesZinaida Polonskaya, Shenglou Deng, Anita Sarkar, et al.
CJC Open|March 2, 2026
Secondary Prevention in STEMI Patients: Insights from a Regional Virtual STEMI ClinicMina Garas, Paul Mundra, Brian McGrath, et al.
The British Journal of Surgery|February 15, 2020
Hepatocellular carcinoma tumour burden score to stratify prognosis after resectionD I Tsilimigras, D Moris, J M Hyer, et al.
Pageof 118

Showing results (1101-1110 of 1,180) with videos related to

Sort By:
Pageof 118
European Heart Journal. Cardiovascular Pharmacotherapy|January 17, 2023
Ticagrelor with or without aspirin in high-risk patients with anaemia undergoing percutaneous coronary intervention: a subgroup analysis of the TWILIGHT trialAlessandro Spirito, Adnan Kastrati, Davide Cao, et al.
CJC Open|December 23, 2022
Design and Rationale of Routine <b>U</b>ltrasou<b>N</b>d Gu<b>I</b>dance for <b>V</b>ascular Acc<b>E</b>ss fo<b>R</b> Cardiac Procedure<b>s</b>: <b>A</b> Randomized Tria<b>L</b> (UNIVERSAL)Sulaiman Alrashidi, Marc-André d'Entremont, Omar Alansari, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|August 22, 2018
Clinical chemistry score versus high-sensitivity cardiac troponin I and T tests alone to identify patients at low or high risk for myocardial infarction or death at presentation to the emergency departmentPeter A Kavsak, Johannes T Neumann, Louise Cullen, et al.
Heart and Vessels|January 28, 2022
Use and outcomes of dual antiplatelet therapy for acute coronary syndrome in patients with chronic kidney disease: insights from the Canadian Observational Antiplatelet Study (COAPT)Carol Anne Graham, Mary K Tan, Derek P Chew, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|June 29, 2023
No-reflow after primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction: an angiographic core laboratory analysis of the TOTAL TrialMarc-André d'Entremont, Ashraf Alazzoni, Vladimir Dzavik, et al.
European Heart Journal|March 28, 2012
The relationship between CYP2C19 polymorphisms and ischaemic and bleeding outcomes in stable outpatients: the CHARISMA genetics studyDeepak L Bhatt, Guillaume Paré, John W Eikelboom, et al.
Journal of the American College of Cardiology|April 3, 2020
Ticagrelor With or Without Aspirin in High-Risk Patients With Diabetes Mellitus Undergoing Percutaneous Coronary InterventionDominick J Angiolillo, Usman Baber, Samantha Sartori, et al.
The Journal of Clinical Investigation|March 14, 2017
T cells control the generation of nanomolar-affinity anti-glycan antibodiesZinaida Polonskaya, Shenglou Deng, Anita Sarkar, et al.
CJC Open|March 2, 2026
Secondary Prevention in STEMI Patients: Insights from a Regional Virtual STEMI ClinicMina Garas, Paul Mundra, Brian McGrath, et al.
The British Journal of Surgery|February 15, 2020
Hepatocellular carcinoma tumour burden score to stratify prognosis after resectionD I Tsilimigras, D Moris, J M Hyer, et al.
Pageof 118